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Abstract
Background: Common, complex diseases are hypothesized to result from a combination of common and rare
genetic variants. We developed a unified framework for the joint association testing of both types of variants.
Within the framework, we developed a union-intersection test suitable for genome-wide analysis of single
nucleotide polymorphisms (SNPs), candidate gene data, as well as medical sequencing data. The union-intersection
test is a composite test of association of genotype frequencies and differential correlation among markers.
Results: We demonstrated by computer simulation that the false positive error rate was controlled at the expected
level. We also demonstrated scenarios in which the multi-locus test was more powerful than traditional single
marker analysis. To illustrate use of the union-intersection test with real data, we analyzed a publically available
data set of 319,813 autosomal SNPs genotyped for 938 cases of Parkinson disease and 863 neurologically normal
controls for which no genome-wide significant results were found by traditional single marker analysis. We also
analyzed an independent follow-up sample of 183 cases and 248 controls for replication.
Conclusions: We identified a single risk haplotype with a directionally consistent effect in both samples in the
gene GAK, which is involved in clathrin-mediated membrane trafficking. We also found suggestive evidence that
directionally inconsistent marginal effects from single marker analysis appeared to result from risk being driven by
different haplotypes in the two samples for the genes SYN3 and NGLY1, which are involved in neurotransmitter
release and proteasomal degradation, respectively. These results illustrate the utility of our unified framework for
genome-wide association analysis of common, complex diseases.
Background
Mapping disease susceptibility loci for complex diseases
has proven to be challenging. The etiology of a complex
disease is multifactorial, with both genetic and environ-
mental risk factors and interactions among these risk
factors. Genome-wide association (GWA) studies are an
alternative to traditional family-based linkage studies for
mapping disease susceptibility loci for complex diseases.
The most common design to date for GWA studies is
to genotype a dense panel (> 100,000) of single-nucleo-
tide polymorphisms (SNPs) for a large collection of
unrelated cases and controls. SNPs are then tested one
marker at a time for association most often using con-
tingency table analysis, i.e., a X
2test or Fisher’s exact test
with one or two degrees of freedom, depending on the
hypothesis being tested. The resulting set of p-values is
then adjusted for multiple comparisons, usually a Bon-
ferroni correction for the number of tests performed.
Single marker analysis involves the marginalization of
effects over all genetic and environmental back-
grounds. Consequently, effect sizes for single markers
tend to be small (odds ratios of 1.2 to 1.5 per copy of
the risk allele or smaller), necessitating sample sizes of
thousands to obtain reasonable levels of power at gen-
ome-wide significance levels [1]. Multi-locus methods
may have increased power if they account for the cor-
relation of loci due to linkage disequilibrium. However,
multi-locus methods generally have been observed to
have decreased power because they tend to produce
test statistics with larger degrees of freedom [2].
Therefore, in designing a powerful and efficient multi-
locus method for generating testable hypotheses based
on genome-wide SNP data, we are motivated to reduce
the degrees of freedom.
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ing of many genes, which may be located on different
chromosomes and hence may segregate independently.
This motivation raises the general question of how to
test a set of markers that may be biologically related but
not correlated via linkage disequilibrium. Possibilities
include multivariate techniques such as the F test or
multiple regression. However, these techniques can also
lose power due to large degrees of freedom.
A third issue for association analysis is low power for
rare variants that medical sequencing is expected to
uncover. To overcome low power for variants with fre-
quencies < 5%, specialized methods for grouping variants
have been described [3,4], but such methods were
designed only for analysis of rare variants for which link-
age disequilibrium is expected to be negligible. Further-
more, the two most commonly used estimators of linkage
disequilibrium, r
2 and D’, are biased upwards when allele
frequencies are low or sample sizes are small [5,6].
In response to all of these motivations, we propose a
flexible multi-locus method based on unions of multiple
SNPs that yields a test that always has only one degree
of freedom. The method implicitly accounts for linkage
disequilibrium and is appropriate for simultaneous ana-
lysis of common and rare variants. We demonstrate by
simulation that our method has valid control of the false
positive error rate while yielding more power than tradi-
tional single marker analysis. We also demonstrate by
simulation that our method is sensitive to any source of
differential correlation among markers. We then analyze
two publicly available data sets for Parkinson disease
(PD) for which no significant associations were detected
by single marker analysis [7-9]. Using our new method,
we found evidence supporting susceptibility to PD at
three loci.
Methods
Study Samples
Parkinson disease (MIM 168600, http://www.ncbi.nlm.
nih.gov/omim) is the second most common neurodegen-
erative disorder after Alzheimer disease. For the discov-
ery sample, we obtained publicly available data from the
PROGENI and GenePD studies of familial PD [9]. Briefly,
2,082 cases and controls were genotyped using Illumina
HumanCNV370 version1_C BeadChips (Illumina, San
Diego, CA) and the Illumina Infinium II assay protocol.
For the replication sample, we obtained publicly avail-
able data from a study of sporadic PD from the SNP
Resource at the National Institute of Neurological Dis-
orders and Stroke Human Genetics Resource Center
DNA and Cell Line Repository http://ccr.coriell.org/
ninds/ as well as clinical data [7,8]. The original geno-
typing was performed in the laboratory of Drs. Andrew
Singleton and John A. Hardy (National Institute on
Aging, Laboratory of Neurogenetics), Bethesda, MD
USA. Briefly, 408,803 SNPs were genotyped using the
Illumina Infinium I and HumanHap300 assays on
270 cases and 270 neurologically normal controls. The
data made available had already been processed for
quality control [7].
The Framework of Logical Unions
To illustrate the construction of a union based on classical
(binary) logic, consider two events. Let P(X) be the prob-
ability of event X and P(Y) be the probability of event Y.
The probability of the union of events X and Y, p (X ∪ Y),
is P (X ∪ Y)=P (X)+P (Y)-P (X ∩ Y). To estimate the
probability of the intersection P (X ∩ Y), we need a
measure of correlation. One commonly used measure of
correlation is the pairwise correlation coefficient,
givenby r
XY
XY
PX Y PXPY
PX PX PY PY
= ()
() ()
=
∩ () − () ()
()− () () () −
cov
var var
,
11 ( () () .
After rearrangement and substitution,
PX Y PX PY PXPY rPX PX PY PY ∪= + − − − − ( ) () () ()() () () () () () () 11 .
In the genetic context, let A represent the major allele
and B represent the minor allele at a SNP. With respect
to the minor allele, dominant coding of the three geno-
types (AA,AB,BB) is given by (0,1,1) and recessive cod-
ing is given by (0,0,1). Additive coding of the number of
copies of the minor allele, i.e.,(0,1,2), can be achieved by
summing over dominant and recessive variables since
(0,1,1) + (0,0,1) = (0,1,2) and thus need not be separately
considered [10]. r
2 is a commonly used measure of link-
age disequilibrium. Thus, unions implicitly account for
correlation between markers, including coupling (r >0 )
or repulsion (r < 0) phase. It is critical to note that this
use of the correlation coefficient encompasses gametic
phase disequilibrium as well as other sources of correla-
tion such as epistasis and natural selection. Also note
that, by definition, P (X ∪ X)=P(X), demonstrating the
equivalence of analysis of a union of one marker with
traditional single marker analysis.
There are many possible coding schemes one could
implement within this framework. In this study, we con-
struct unions over consecutive, non-overlapping sets of k
markers. The choice of non-overlapping sets was made
to facilitate calculating the genome-wide testing burden.
Let xij be a binary indicator variable for the i
th individual
and the j
th union. With two markers (loci denoted by
subscripts) under dominant coding for the minor allele,
xij
AAAA
ABAA BBAA A
=
0 1122
1
112 2 112 2
for genotype
for genotypes
,, 1 1122 1122 1122
1122 1122 1122
1
A A BA A B BA B A B
ABBB BBAB BBBB
,,,
,,
for g genotypes ? ? ? ? ? ? ? ?
? for genotype
AB BB AB BB 1122 1122 1 122 1 122 ,,,
s s ?? ?? ???? AA AA 1 122 11 2 2 1122 ,,
,
⎧
⎨
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⎪ ⎪
⎩
⎪
⎪
⎪
in which ? represents missing data. Under dominant
coding, a value of 0 indicates the absence of at least one
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value of 1 indicates the presence of at least one B allele
(the alternative hypothesis is the union). Similarly, with
two markers under recessive coding for the minor allele,
xij
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0 1122 1122 1122 1122
1
for genotypes
for 
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for
AABB ABBB BBAA
BBAB BBBB
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Under recessive coding, a value of 0 indicates the
absence of at least one BB genotype (the null hypothesis
is the intersection) and a value of 1 indicates the pre-
s e n c eo fa tl e a s to n eBB genotype (the alternative
hypothesis is the union). Any individual for which xij =
? is removed from analysis of the j
th union. Note that
this choice of implementation relies solely on counting
individuals with pre-specified multi-locus genotypes,
does not require estimation of pi, pj,o rr, and does not
assume Hardy-Weinberg equilibrium.
For case-control data, we test for association using
Fisher’s exact test. For the j
th union, the 2 × 2 contin-
gency table is constructed by counting the numbers of
individuals for which xij is 0 or 1 among cases and con-
trols. The test has only one degree of freedom, regard-
less of k. We control for multiple comparisons using a
Bonferroni correction for the number of unions tested.
The number of unions tested is given by
#SNPs
k
⎡
⎢ ⎢
⎤
⎥ ⎥ ,i n
which ┌x┐ is the ceiling function and returns the smal-
lest integer not less than x. This implementation of mul-
tiplicity control preserves more power as k increases and
as the testing burden is consequently reduced. Given
319,813 SNPs in the discovery sample and accounting
for both dominant and recessive coding over unions of
size one to five, the genome-wide significance level was
00 5
2 319 813
34 2 1 0
1
5
8 .
,
.
× ⎡
⎢ ⎢
⎤
⎥ ⎥
=×
=
−
∑ k k
. All union testing was per-
formed in R [11].
Other Analyses
Imputation was performed using MACH, version
1.0.16 http://www.sph.umich.edu/csg/abecasis/MACH/
download/. For the reference panel, we retrieved the com-
bined HapMap phase II+III raw genotype files for the
CEU sample http://hapmap.ncbi.nlm.nih.gov/downloads/
genotypes/latest_phaseII+III_ncbi_b36/forward/non-
redundant/. We filtered the 3,907,239 autosomal CEU
SNPs based on the inclusion of unrelated individuals only,
a minor allele frequency ≥ 0.01, a SNP missingness rate ≤
5%, and an individual missingness rate ≤ 5%. We inferred
haplotype phases for the reference data using the settings
–rounds 50 –states 200. We conditioned imputation on
the maximum-likelihood estimates of the crossover map
and the error rate map. We retained all imputed genotype
calls for which the posterior probability ≥ 0.9.
We performed haplotype analysis using PLINK version
1.06 http://pngu.mgh.harvard.edu/purcell/plink/ [12].
Briefly, we compared each haplotype against all of the
other haplotypes.
Results
Simulation Analysis
We first investigated the validity and power of our pro-
posed method, exploring over sizes of unions of SNPs
ranging from one to five. Note that analysis of a union
of one SNP is identical to single marker analysis. Under
the null hypothesis of no association, analysis of unions
has the expected per comparison error rate and is there-
fore valid (Figure 1A). For small effect sizes (odds ratios
≤ 2), analysis of unions is increasingly more powerful
than single marker analysis as the frequency of the
minor multi-locus genotype decreases (Figs. 1B and 1C).
If a union consists of both risk-increasing and risk-
decreasing predictors, effects will cancel and power will
be lost (Figure 1D). Also, if a union consists of too
many predictors with no effect on the outcome, then
power to detect a predictor with an effect within the
union will decrease (Figure 1E). Analysis of unions of
correlated predictors can be more powerful than analysis
of unions of independent predictors (Figure 1F). Epista-
sis (nonadditivity on the logit scale) can either increase
or decrease power, depending on the directions of the
effect sizes for epistatic effects vs. marginal effects
(Figure 1G). For epistasis to be detectable, minor geno-
type frequencies must be large so that the joint geno-
type counts are reasonably large.
The union test is a valid test of association of geno-
type frequencies if the correlation between markers is
matched in cases vs. controls (Figure 1F). The union
test is also a powerful test of differential correlation
among markers, even in the absence of differences in
genotype frequencies (Figure 1H). Thus, the union test
can simultaneously detect differences in genotype fre-
quencies, epistasis, haplotype structure, natural selection,
population structure, and any other process affecting
correlation among markers.
Comparison to Other Methods
We compared the union test to a logistic kernel machine-
based test, a set-based test for common variant analysis
that adaptively estimates the degrees of freedom given
the correlational structure of the markers in the set
[2,13]. Both tests were valid at the 0.05 significance level
(Additional File 1). The union test was more powerful
than the kernel machine-based test for multiple indepen-
dent markers with nonzero effects (Additional File 2 and
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Figure 1 Validity and power analysis of union testing. Each simulated data set consisted of 938 cases and 863 controls. For each experiment,
1,000 independent replicates were simulated. Coded genotypes were simulated by randomly sampling from a binomial distribution with the
given frequencies. Case-control status was determined by a logistic model. Gray lines indicate the per comparison significance threshold of 0.05.
A) Per comparison error rate. Unions of one, two, three, four, and five SNPs are represented by black, red, orange, green, and blue lines,
respectively. B) Power for an odds ratio of 1.5 for each SNP. C) Power for an odds ratio of 2 for each SNP. D) Power for 2-marker unions with
opposing effects. The black line represents odds ratios of 2 and 0.5 for the two markers, the red line represents 1.5 and 0.67, and the blue line
represents 1 and 1. E) Power for unions consisting of one predictor with an odds ratio of 2 (black line), 1.5 (red line), or 1 (blue line), and four
predictors with odds ratios of 1. F) Power for 2-marker unions with correlated predictors. Solid lines represent independent predictors and
dotted lines represent predictors correlated at r
2 = 0.8. Black lines represent odds ratios of 2, red lines represent 1.5, and blue lines represent 1.
G) Power to detect epistasis for 2-marker unions. The black line represents odds ratios of 1 for both markers and 1 for the epistatic effect. The
red line represents odds ratios of 1 for both markers and 2 for the epistatic effect. The blue line represents odds ratios of 1 for both markers and
0.5 for the epistatic effect. H) Power to detect differential correlation between 2-marker unions. Black lines represent r
2 = 0 in controls and r
2 =
0.8 in cases. Red lines represent r
2 = 0.8 in controls and r
2 = 0 in cases. Solid lines represent odds ratios of 2 and dotted lines represent 1.
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Page 4 of 11Additional File 3). The union test was also more powerful
than the kernel machine-based test when the minor gen-
otype frequency was below ~0.10 (Additional File 2 and
Additional File 3). The kernel machine-based test was
more powerful than the union test for markers with
opposing effects (Additional File 4), dilute signal (Addi-
tional File 5), correlated predictors (Additional File 6),
and epistasis (Additional File 7). The kernel machine-
based test was conservative in the presence of differential
correlation between markers under the null hypothesis
and had no power to detect differential correlation under
the alternative hypothesis (Additional File 8).
We also compared the union test to the collapsing
method [3], a set-based test for rare variant analysis that
collapses the data into a X
2 test with one degree of free-
dom. The collapsing method is based on aggregating gen-
otypes across all loci in the set such that “an individual is
coded as 1 if a rare allele is present at any of the variant
sites and as 0 otherwise” [3]. Thus, the collapsing method
is in fact identical to the union test (under dominant cod-
ing) by construction and power is equivalent for both
tests. The two main differences between the collapsing
method and the union test are that the former assumes
that minor allele frequencies are low, i.e., ≤ 0.05, and that
all markers are independent, i.e., there is no linkage dise-
quilibrium (r
2 = 0) [3]. The collapsing method is thus a
special case of the union test, with the union test applic-
able across the entire range of frequencies and across the
entire range of linkage disequilibrium.
Real Data Analysis
Data processing for quality control for both samples is
depicted in Figure 2. For the discovery sample, we
retained 938 of the 1,073 cases, 863 of the 1,009 controls,
and 319,813 of the 344,301 SNPs. For the replication
sample, we retained 183 of the 270 cases, 248 of the
270 controls, and 379,017 of the 408,803 SNPs. To
investigate the possibility of population stratification in
the discovery and replication samples, we estimated the
variance inflation factor of the genomic control method
[14,15]. We estimated an inflation factor of 1.05 for the
discovery sample and 1.01 for the replication sample,
indicating a negligible inflation of the false positive error
rate due to population stratification (Additional File 9).
Under dominant coding, we identified no regions corre-
lated with PD case/control status at a genome-wide signifi-
cance level of 3.42 × 10
-8 (Figure 3A). We identified seven
independent loci at suggestive levels of association
(Table 1). Of these, we replicated the region on chromo-
some 4p16 including the gene GAK. This region was dis-
covered using unions of one, two, or three markers but
was replicated only in the single marker analysis (Table 1).
Using haplotype analysis, we found that the association in
both samples was driven by the same low-frequency hap-
lotype (TT) with an odds ratio of 1.58 (Table 2).
To directly compare single marker analysis, haplotype
analysis, and our multi-locus method, we examined the
first multi-locus union in Table 1, which consisted of
SNPs rs1564282 and rs2061846, using the replication
sample (Figure 4A). By 2 × 3 contingency table analysis
of genotypes, rs1564282 was significantly associated with
PD (Figure 4B) but rs2061846 was not (Figure 4C).
Similarly, by 2 × 2 contingency table analysis under
dominant coding, rs1564282 was significantly associated
with PD (Figure 4D) but rs2061846 was not (Figure 4E).
Haplotype analysis revealed significant association with
PD for the haplotype consisting of the minor allele at
rs1564282 and the major allele at rs2061846, i.e., haplo-
type TT vs. haplotypes CC and CT with haplotype TC
being unobserved (Figure 4F). Under dominant coding,
2 × 2 contingency table analysis of the union did not
yield significant association, because the union tested
multi-locus genotype CCTT vs. the other eight geno-
types, effectively attenuating the signal of haplotype TT
(Figure 4G).
In general, for a union over k SNPs, the number of
joint genotypes is 3
k and 2 × 2 contingency table analy-
s i si sm o r ep o w e r f u lt h a n2×3
k contingency table ana-
lysis. More importantly, as k increases, some joint
genotypes likely will be unobserved, leading to cells in
the contingency table having counts of zero. Collapsing
a2×3
k contingency table into a 2 × 2 contingency
table is one way to address this problem of data sparsity.
In our implementation of dominant coding over multi-
ple loci, the reference multi-locus genotype consists
solely of diplotypes of the most common haplotype.
This example (Figure 4) illustrates the trade-off of gain-
ing power by reducing the degrees of freedom vs. losing
power by attenuation of signal.
Under recessive coding, we identified no regions corre-
lated with PD case/control status at a genome-wide sig-
nificance level of 3.42 × 10
-8 (Figure 3B). At suggestive
significance levels, we identified two potentially interest-
ing loci at chromosomes 3p24 and 22q12 (Table 1). At
chromosome 3p24, SNP rs9310784 was associated with
decreased risk in the discovery sample but with increased
risk in the replication sample. We investigated this direc-
tional inconsistency locus using haplotype analysis
(Table 3). We identified a haplotype block of eight SNPs
including rs9310784. In the discovery sample, the haplo-
type with the strongest effect carried the minor allele at
rs9310784 and was associated with decreased risk. In the
replication sample, the haplotype with the strongest
effect carried the major allele and was associated with
increased risk. Thus, the effects were directionally consis-
tent at the haplotypic level with respect to rs9310784 but
Shriner and Vaughan BMC Genomics 2011, 12:89
http://www.biomedcentral.com/1471-2164/12/89
Page 5 of 11were directionally inconsistent with respect to marginal
effects at this SNP. At chromosome 22q12, the marginal
effects for SNP rs1159220 were directionally inconsistent
(Table 1) and different haplotypes drove association in
the two samples (Table 4).
Finally, we examined execution time for the union
test. Algorithmically, the union test consists of one
hypothesis test per union, regardless of the number of
markers in the union. For a union of k markers, the
union test is approximately k-1 times faster than the
Figure 2 Quality control. A) Sample processing for the discovery sample. B) SNP processing for the discovery sample. C) Sample processing for
the replication sample. D) SNP processing for the replication sample.
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tional burden of taking the union is less than the com-
putational burden of performing one Fisher’s exact test.
Discussion
Recent attempts at elucidating the underlying genetic
structure of common, complex diseases have been ham-
pered by the use of methods that do not account for
correlation in the data, are overly stringent, and are
underpowered in the presence of allelic or locus hetero-
geneity and rare variants. Compared to other multi-
locus methods designed to address these issues, unions
offer many advantages, including accounting for linkage
disequilibrium, epistatic interactions within (but not
between) unions, and haplotype structure, with no
requirement for the estimation of haplotypes or phase.
Union testing can be viewed as a generalization of
grouping schemes for analysis of independent rare var-
iants [3,4] that allows for arbitrary patterns of correla-
tion among common and/or rare variants. An additional
advantage is that the counting algorithm implicitly
accounts for correlation without explicit and potentially
biased estimation of linkage disequilibrium measures
and without the need of permutation testing to establish
correct type I error rates. Union tests can be more
powerful than single marker tests because they make
fuller use of the information (i.e., genotype frequencies
and multi-locus linkage disequilibrium [16]) in a multi-
variable framework. Power may also be gained by
collapsing multi-locus genotype information into a sin-
gle degree of freedom test [3].
The union test is a composite test of association of gen-
otype frequencies and differential correlation among mar-
kers. Union tests are also haplotype tests and are sensitive
to processes such as natural selection and population
structure that may lead to differential correlation among
markers. Previous analyses did not detect substantial
population structure in either PD data set [7]. However,
given that our multi-locus method is more powerful than
single marker analysis under many genotypic configura-
tions, it is possible that our method is more sensitive to
cryptic relatedness or residual population stratification
than is single marker analysis. To better address this issue,
regression with a covariate for parental ancestry provides a
framework compatible with unions [17].
O u rp r o p o s e dm e t h o di sv e r yf l e x i b l e .T h ec h o i c eo f
which SNPs to combine into unions belongs to the inves-
tigator. We chose to combine consecutive SNPs in non-
overlapping sets in order to take advantage of linkage dis-
equilibrium, so that union testing may be viewed as a
generalization of haplotype testing, while minimizing the
correlation between tests. With an appropriate grouping
scheme, unions may be used to address allelic heteroge-
neity, which occurs when the phenotype of interest is
caused by different mutations within the same gene [18].
T h er o l eo fa l l e l i ch e t e r o g e n e i t yi nc o m p l e xd i s e a s ei s
exemplified by the several, individually rare mutations in
NOD2 associated with Crohn’s disease [19]. Alternatively,
Figure 3 Genome-wide scans for single marker analysis. The red horizontal line indicates the significance level of 3.42 × 10
-8.
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minor allele frequencies < 5%. Rare variants have been
predicted to play an important role in complex diseases
[20], as has been illustrated for colorectal cancer [21] and
cholesterol metabolism [22]. Unions may also be used to
address genetic heterogeneity, which occurs when multi-
ple genes cause the same disease.
Although we tested unions using contingency table
analysis, it is straightforward to adapt our coding for use
with generalized linear models and thus to incorporate
covariates into the analysis. Our method is also flexible
with respect to genetic models, such that coding for
SNPs may be any combination of dominant, additive, or
recessive [23]. Depending on the implementation (e.g.,
non-overlapping windows), union testing can also
reduce the testing burden compared to single marker
analysis. However, instead of non-overlapping windows
as we used herein, a sliding window approach could be
employed, at the cost of a higher testing burden.
There are two main disadvantages of unions. One dis-
advantage is that the SNP(s) and/or haplotype(s) within
a union driving association cannot be inferred. If gen-
ome-wide analysis is intended as exploratory and
hypothesis-generating, then this disadvantage is not a
concern. The second disadvantage is that there are sce-
narios under which statistical power may be lost,
depending on how collapsing is achieved. As with other
collapsing methods, the power of union testing
decreases if the size of the union is too large, whether
or not the included variants are causal [3]. This limita-
tion is more pronounced for markers with large minor
allele frequencies. Similarly, the power of union testing
decreases if both risk-increasing and risk-decreasing
effects are included within a union. One approach to
Table 1 Summary of discovery and replication results
Model Size Discovery
P-value
OR (95% CI) Replication
P-value
OR (95% CI) rsid Chr Position
(bp)
Minor/major
allele
Gene
Dominant 1 8.17 × 10
-6 0.65 (0.54, 0.79) 0.845 1.04 (0.69, 1.56) rs1584586 3 151677041 A/G TSC22D2
Dominant 1 6.70 × 10
-6 1.71 (1.35, 2.18) 0.037 1.69 (1.02, 2.81) rs1564282 4 842313 T/C GAK
Dominant 1 4.03 × 10
-6 1.73 (1.36, 2.21) NA NA rs11248051 4 848332 T/C GAK
Dominant 1 8.25 × 10
-6 1.67 (1.32, 2.11) 0.033 1.66 (1.02, 2.71) rs11248060 4 954359 T/C GAK
Dominant 1 1.89 × 10
-6 12.95 (3.24, 112.76) NA NA rs7848576 9 697463 G/A ANKRD15
Dominant 1 3.37 × 10
-6 0.64 (0.53, 0.78) 0.560 0.89 (0.60, 1.33) rs898528 17 74678398 T/C NA
Dominant 1 6.84 × 10
-6 0.65 (0.54, 0.79) 0.283 1.25 (0.84, 1.87) rs2830713 21 27416311 T/C NA
Dominant 2 1.77 × 10
-6 1.58 (1.30, 1.91) 0.202 1.30 (0.87, 1.95) rs1564282 4 842313 T/C GAK
rs2061846 4 842484 C/T GAK
Dominant 2 2.24 × 10
-6 1.57 (1.30, 1.90) NA NA rs4690339 4 844712 G/A GAK
rs11248051 4 848332 T/C GAK
Dominant 2 2.91 × 10
-6 0.63 (0.52, 0.77) 0.252 1.28 (0.84, 1.97) rs194907 6 82485214 G/A FAM46A
rs1276888 6 82489107 T/C FAM46A
Dominant 3 1.40 × 10
-6 1.58 (1.31, 1.92) NA NA rs1564282 4 842313 T/C GAK
rs2061846 4 842484 C/T GAK
rs4690339 4 844712 G/A GAK
Dominant 3 9.55 × 10
-6 0.62 (0.50, 0.77) 1.000 1.01 (0.65, 1.58) rs1881747 10 54003581 C/T NA
rs1919764 10 54015996 C/T NA
rs1919738 10 54021111 A/G NA
Dominant 4 5.06 × 10
-6 0.61 (0.49, 0.76) 0.914 0.98 (0.63, 1.54) rs7085224 10 53971746 G/A NA
rs1881747 10 54003581 C/T NA
rs1919764 10 54015996 C/T NA
rs1919738 10 54021111 A/G NA
Recessive 1 7.25 × 10
-6 0.22 (0.09, 0.46) 0.060 3.72 (0.88, 22.09) rs9310784 3 25905208 C/T NGLY1
Recessive 1 2.26 × 10
-6 1.65 (1.33, 2.04) 0.182 0.73 (0.45, 1.16) rs2382722 16 27300127 G/A IL4R,
IL21R
Recessive 1 5.36 × 10
-6 0.56 (0.43, 0.72) 0.078 1.65 (0.94, 2.91) rs1159220 22 31410753 T/C SYN3
Recessive 1 6.14 × 10
-6 0.56 (0.43, 0.73) 0.078 1.65 (0.94, 2.91) rs3788483 22 31414345 C/T SYN3
Recessive 2 8.33 × 10
-6 2.06 (1.48, 2.90) 0.521 1.26 (0.64, 2.48) rs2189387 17 36293632 A/G KRT20
rs7212483 17 36294578 T/C KRT20
Recessive 2 7.75 × 10
-6 0.57 (0.44, 0.74) 0.164 1.45 (0.86, 2.45) rs1159220 22 31410753 T/C SYN3
rs5998577 22 31412043 A/G SYN3
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Page 8 of 11B. rs1564282 – additive (OR=1.58, p = 0. 0496) C. rs2061846 – additive (OR=0.92, p = 0.811)
D. rs1564282 – dominant (OR=1.69, p = 0.0370) E. rs2061846 – dominant (OR=0.94, p = 0.827)
G. Union – dominant (OR=1.30, p = 0.202)
A. Joint genotype counts for rs1564282 (locus 1) and rs2061846 (locus 2)
F. Haplotype
CCTT CCTC CCCC CTTT CTTC CTCC TTTT TTTC TTCC
Controls 145 53 10 31 6 0 2 0 0
Cases 95 38 5 38 6 0 1 0 0
CC CT TT
Controls 208 38 2
Cases 138 44 1
TT TC CC
Controls 178 59 10
Cases 134 44 5
CC T-
Controls 208 40
Cases 138 45
TT C-
Controls 178 69
Cases 134 49
Frequency
in cases
Frequency
in controls
Odds 
Ratio
P-
value
CC 0.1475 0.1599 0.92 0.634
TT 0.1257 0.08502 1.58 0.0489
CT 0.7268 0.7551 0.87 0.356
CCTT CCC- or T-TT or T-C-
Controls 145 103
Cases 95 88
Figure 4 Comparison of single marker and multi-locus methods. A) The observed joint genotype counts for rs1564282 and rs2061846. One
control with the CT genotype at rs1564282 had a missing genotype at rs2061846. B) Single marker analysis for rs1564282 under additive coding.
C) Single marker analysis for rs2061846 under additive coding. D) Single marker analysis of rs1564282 under dominant coding. E) Single marker
analysis of rs2061846 under dominant coding. “-” indicates either allele. F) Haplotype analysis. G) Union analysis under dominant coding.
Table 2 Haplotype analysis for the locus at chromosome 4p16
Discovery Replication
Haplotype
a Frequency Odds Ratio P-value Frequency Odds Ratio P-value
CC 0.173 1.17 0.075 0.155 0.92 0.634
TT 0.111 1.59 2.10 × 10
-5 0.102 1.58 0.049
CT 0.716 0.72 9.86 × 10
-6 0.743 0.87 0.356
aIn order, the SNPs are rs1564282 and rs2061846.
Table 3 Haplotype analysis for the locus at chromosome 3p24
Discovery Replication
Haplotype
a Frequency Odds Ratio P-value Frequency Odds Ratio P-value
ACGCCAAT 0.799 0.98 0.835 0.782 0.83 0.248
GTATTGCC 0.072 0.76 0.040 0.105 1.01 0.974
GTATTAAT 0.033 1.42 0.069 0.043 0.73 0.365
GCACTACT NA NA NA 0.014 7.11 0.012
GTATTACC 0.033 0.99 0.969 0.041 2.07 0.058
GCATCACC 0.038 1.27 0.195 NA NA NA
aIn order, the SNPs are rs4481118, rs4293672, rs6551000, rs6793031, rs1991332, rs7644516, rs2052760, and rs9310784.
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Page 9 of 11address both attenuation and cancellation of signal is to
use a mixture model with one component for risk-
increasing effects, one component for risk-decreasing
effects, and one component for null effects.
We illustrated union testing by reanalyzing genome-
wide genotype data for Parkinson disease. As expected,
our findings represent a superset of those originally
described [9]. SNP rs9310784 is 105 kb upstream of the
gene NGLY1 (GeneID 55768), which encodes an enzyme
thought to participate in proteasomal degradation of mis-
folded glycoproteins [24]. SNP rs1564282 is intronic in the
gene GAK (GeneID 2580), which regulates clathrin-
mediated membrane trafficking [25]. In the original analy-
sis of these data, GAK was found to be associated under
an additive model [9], although our analysis revealed that
the association at this locus resulted from a dominant
effect. Linkage disequilibrium levels are moderate to
strong over a 186 kb region including GAK as well as five
other genes, leading to poor resolution at this locus. SNPs
rs1159220 and rs5998577 are intronic in the gene
SYN3 (GeneID 8224). Synapsins are essential for assembly
of synaptic vesicles and modulate neurotransmitter release,
with expression of SYN3 being neuron-specific [26]. As
with other genome-wide association studies, the power of
our analysis was limited by small effect sizes and small
sample sizes, particularly a small replication sample.
We have developed a unified framework using unions of
multi-locus genotypes to powerfully, flexibly, and efficiently
analyze genome-wide genotype data, candidate gene data,
or medical sequencing data. Implementation with standard
statistical packages (we used R) is straightforward. We
replicated as significantly affecting PD risk a single, low-fre-
quency haplotype in the region of the GAK gene on chro-
mosome 4 and identified two other regions with suggestive
evidence of multiple low-frequency risk haplotypes.
Conclusions
Recent attempts at elucidating the genetic architecture
of complex traits have been hampered by the use of
methods that do not account for correlation in the data,
are overly stringent, and are underpowered in the pre-
sence of allelic or locus heterogeneity and rare variants.
To address these issues, we developed a powerful and
efficient multivariable method based on unions of
variants. Our method produces multivariable test statis-
tics with reduced degrees of freedom compared to hap-
lotype-based methods, implicitly accounts for linkage
disequilibrium, and reduces the testing burden. Our
method also generalizes collapsing methods as pre-
viously described for analysis of rare variants. Thus, we
provide a unified framework for the analysis of one or
more variants with any pattern of linkage disequilibrium
and with any minor genotype frequency. Our method is
suitable for genome-wide genotype data, candidate gene
data, exome sequencing data, and whole genome
sequencing data. Using our new method, we found evi-
dence supporting susceptibility to PD at three loci.
Additional material
Additional File 1: Table comparing the validity of the union test
and the kernel machine-based test. See the legend for Figure 1A for
details.
Additional File 2: Table comparing the power of the union test and
the kernel machine-based test for multiple independent markers
with moderate effects. See the legend for Figure 1B for details.
Additional File 3: Table comparing the power of the union test and
the kernel machine-based test for multiple independent markers
with larger effects. See the legend for Figure 1C for details.
Additional File 4: Table comparing the power of the union test and
the kernel machine-based test for markers with opposing effects.
See the legend for Figure 1D for details.
Additional File 5: Table comparing the power of the union test and
the kernel machine-based test for dilute signal. See the legend for
Figure 1E for details.
Additional File 6: Table comparing the power of the union test and
the kernel machine-based test for correlated predictors.See the
legend for Figure 1F for details.
Additional File 7: Table comparing the power of the union test and
the kernel machine-based test for epistasis. See the legend for Figure
1G for details.
Additional File 8: Table comparing the power of the union test and
the kernel machine-based test for differential correlation between
markers. See the legend for Figure 1H for details.
Additional File 9: Quantile-quantile plots for genomic control.A )T h e
discovery sample. B) The replication sample. The red lines indicate the
expected distribution. The inflation factors are shown, indicated by lGC.
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